Innovation Pharmaceuticals Inc (IPIX)

[FlashingLeather]

I certainly can't cite any PRs but my take on the issue is that the extra patients resulted from a final, mad screening scramble to make sure that enough (>= 189) participants were in the trial by the end of August, thus guaranteeing an end of December, end of Q4, on-time trial completion.

Given mgmt's defensive handling of the ostensibly benign interim report cancellation, there's no way in Hades that Leo wanted to announce to the market a trial delay from Q4 to 1Q18...no way, no how.

Or can you cite a pr or filing where ipix claims they PURPOSEFULLY and INTENTIONALLY added these extra patients?